Author Correction: Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Author Correction: Prostate-specific extracellular vesicles as a novel biomarker in human prostate cancer ; volume:9 ; number:1 ; day:15 ; month:4 ; year:2019 ; pages:1 ; date:12.2019
Scientific reports ; 9, Heft 1 (15.4.2019), 1, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Park, Yong Hyun
Shin, Hyun Woo
Jung, Ae Ryang
Kwon, Oh Sung
Choi, Yeong-Jin
Park, Jaesung
Lee, Ji Youl
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-41385-w
- URN
-
urn:nbn:de:101:1-2019042813570680766765
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Yong Hyun
- Shin, Hyun Woo
- Jung, Ae Ryang
- Kwon, Oh Sung
- Choi, Yeong-Jin
- Park, Jaesung
- Lee, Ji Youl
- SpringerLink (Online service)
Other Objects (12)
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Role of extracellular vesicles in bone-prostate cancer cross-talk
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Role of extracellular vesicles in bone-prostate cancer cross-talk
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice
Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines
Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
Any decline in prostate-specific antigen levels identifies survivors scheduled for prostate-specific membrane antigen-directed radioligand therapy
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy
The Additional Value of Free Prostate Specific Antigen to the Battery of Age-Dependent Prostate-Specific Antigen, Prostate-Specific Antigen Density and Velocity
Prostate cancer risk prediction based on clinical factors and prostate-specific antigen
Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen
Role of extracellular vesicles in bone-prostate cancer cross-talk
Prostate-specific antigen-based screening: controversy and guidelines
Prostate-specific antigen testing accuracy in community practice